Stories | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Stories

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (9)
  • 2024 (6)
  • 2023 (8)
  • 2022 (9)
  • 2021 (15)
  • 2020 (4)
  • 2019 (12)
  • 2018 (4)
Clear All Results
STORY

DEA and Federal Partners Support Continuity of Patient Treatment

December 28, 2023
DEA is committed to making sure patients can get the care they need in the event a doctor or medical facility is unable to provide treatment due to enforcement action against the medical provider. On October 5, 2023, DEA arrested a nurse practitioner in Buffalo, New York, on charges of...
December 28, 2023
STORY

DEA Adds Precursor Chemicals Used to Make Illicit Fentanyl to the Special Surveillance List

October 30, 2023
Fentanyl is the greatest threat facing Americans today. It is a threat to our public health, our public safety, and our national security, and it is the cause of the most devastating drug crisis in United States’ history. The U.S. Drug Enforcement Administration (DEA) is committed to using every tool...
October 30, 2023
STORY

A Message From DEA Administrator Anne Milgram

October 06, 2023
Washington, D.C. – The U.S. Drug Enforcement Administration (DEA) is focused on saving American lives by defeating the cartels responsible for bringing fentanyl into our country. The threat of fentanyl is deadlier and more pervasive than ever before. When I joined DEA in 2021, DEA laboratory testing indicated 4 out...
October 06, 2023
STORY

Five Synthetic Benzodiazepine Drugs Deemed Imminent Hazard to Public Safety

September 25, 2023
On July 26, 2023, DEA temporarily scheduled five synthetic benzodiazepine substances – etizolam, flualprazolam, clonazolam, flubromazolam, and diclazepam – in schedule I of the Controlled Substances Act (CSA). Individuals who handle these substances will now be subject to regulatory controls, as well as to administrative, civil, and criminal sanctions applicable...
September 25, 2023
STORY

DEA and DHS Issue Joint Update on Sources of Illicit Xylazine

September 22, 2023
The U.S. Drug Enforcement Administration and the U.S. Department of Homeland Security are updating the American public on the ongoing threat of illicit xylazine. In April 2023, the White House Office of National Drug Control Policy (ONDCP) designated fentanyl adulterated or associated with xylazine as an emerging threat to the...
September 22, 2023
STORY

Revised Regulation Allows DEA-Registered Pharmacies to Transfer Electronic Prescriptions at a Patient’s Request

September 01, 2023
Patients now have the ability to request their electronic prescription be transferred to another pharmacy without having to go back to their practitioner to initiate the request. This revised regulation went into effect on Monday, August 28, 2023. At a patient’s request, a DEA-registered retail pharmacy can now transfer an...
September 01, 2023
STORY

Albuquerque Employers Benefit from DEA Training and Resources Available Through Operation Engage

August 18, 2023
Following a successful Family Summit on fentanyl in September of 2022, the El Paso Division outreach team has been working with Bernalillo County leadership to create more prevention education opportunities for employers. So, in July as part of Operation Engage, the DEA sponsored a CADCA training which was hosted at...
August 18, 2023
STORY

Overdose Death Investigations Challenge DEA Agents to Bring Justice

February 08, 2023
Deaths from illicit drugs, especially fentanyl, are at historic highs. It’s why Drug Enforcement Administration St. Louis Division investigators are committed to protecting Americans and saving lives by pursuing those responsible. They aim to make sure as many drug traffickers involved in those deaths as possible, get an appearance in...
February 08, 2023
Showing 1 - 8 of 8 results

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español